United Therapeutics Corporation (UTHR) Net income 2016–2025
United Therapeutics Corporation (UTHR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.3BFY2025 · since FY2016: $713.7M → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | +11.7% |
| FY2024 | $1.2B | +21.4% |
| FY2023 | $984.8M | +35.4% |
| FY2022 | $727.3M | +52.9% |
| FY2021 | $475.8M | -7.6% |
| FY2020 | $514.8M | +592.6% |
| FY2019 | -$104.5M | -117.7% |
| FY2018 | $589.2M | +41.0% |
| FY2017 | $417.9M | -41.4% |
| FY2016 | $713.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net marginUTHR Gross profitUTHR Gross marginUTHR Operating incomeUTHR Operating marginUTHR Operating cash flowUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total assetsUTHR Total liabilitiesUTHR Shareholders’ equityUTHR overview →